IMAGE: Lung squamous cell carcinoma

Breaking News

Key: Meeting M      Journal J      Funder F

Showing releases 976-1000 out of 1212.

<< < 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 > >>

Public Release: 12-Mar-2013
PLOS ONE
Using fat to fight brain cancer
In laboratory studies, Johns Hopkins researchers say they have found that stem cells from a patient's own fat may have the potential to deliver new treatments directly into the brain after the surgical removal of a glioblastoma, the most common and aggressive form of brain tumor.
NIH/National Institute of Neurological Disorders and Stroke, Maryland Stem Cell Research Fund

Contact: Stephanie Desmon
sdesmon1@jhmi.edu
410-955-8665
Johns Hopkins Medicine

Public Release: 12-Mar-2013
EMBO Journal
Hereditary neurodegeneration linked to ADP-ribose modification
Researchers have identified a much sought after enzyme that removes ADP-ribose modifications from proteins by studying a genetic mutation that causes neurodegenerative disease in humans. The findings suggest that not only addition but also removal of ADP-ribose from proteins is essential for normal cell function.

Contact: Barry Whyte
barry.whyte@embo.org
49-622-188-91108
European Molecular Biology Organization

Public Release: 12-Mar-2013
Journal of Neurosurgery
Low T3 syndrome predicts unfavorable outcomes in surgical patients with brain tumor
In a study of 90 patients undergoing surgery for brain tumor, researchers in Lithuania and the United States have discovered that the finding of low T3 (triiodothyronine) syndrome is predictive of unfavorable clinical outcomes and depressive symptoms. Details of this study are furnished in the article "Low triiodothyronine syndrome as a predictor of poor outcomes in patients undergoing brain tumor surgery: a pilot study. Clinical article," in the Journal of Neurosurgery.
Research Council of Lithuania

Contact: Jo Ann M. Eliason
jaeliason@thejns.org
434-982-1209
Journal of Neurosurgery Publishing Group

Public Release: 12-Mar-2013
Journal of the National Cancer Institute
Medicare spending for advanced cancer not linked to survival differences
Substantial regional variation in Medicare spending for patients with advanced cancer is not linked to differences in survival, according to a study published March 12 in the Journal of the National Cancer Institute.

Contact: Zachary Rathner
Zachary.Rathner@oup.com
919-677-2697
Journal of the National Cancer Institute

Public Release: 12-Mar-2013
Lancet Oncology
Cancer researchers discover new type of retinoblastoma in babies
A team of Canadian and international cancer researchers led by Dr. Brenda Gallie at the Princess Margaret Cancer Centre, University Health Network, has discovered a new type of retinoblastoma, a rapidly developing eye cancer that affects very young babies -- a finding that can immediately change clinical practice and optimize care for these children.

Contact: Jane Finlayson
jane.finlayson@uhn.ca
416-946-2846
University Health Network

Public Release: 12-Mar-2013
Proceedings of the National Academy of Sciences
Prediction of seasonal flu strains improves chances of universal vaccine
Researchers have determined a way to predict and protect against new strains of the flu virus, in the hope of improving immunity against the disease.

Contact: Rebecca Scott
rebeccas@unimelb.edu.au
61-383-440-181
University of Melbourne

Public Release: 12-Mar-2013
Nature Cell Biology
Asterix's Roman foes -- Researchers have a better idea of how cancer cells move and grow
Researchers at the University of Montreal's Institute for Research in Immunology and Cancer have discovered a new mechanism that allows some cells in our body to move together, in some ways like the tortoise formation used by Roman soldiers depicted in the Asterix series.
Instituts de recherche en sante du Canada, Fonds de recherche du Quebec - Sante

Contact: William Raillant-Clark
w.raillant-clark@umontreal.ca
514-343-7593
University of Montreal

Public Release: 12-Mar-2013
Nature Medicine
Promising new drug treats and protects against radiotherapy-associated oral mucositis
"It's very reasonable to hope that this line of research will result in a drug that patients can self-administer topically to oral mucositis sores, or use to prevent them altogether, thus significantly improving the quality of life for many cancer patients," Wang says.
National Institutes of Health

Contact: Garth Sundem
garth.sundem@ucdenver.edu
University of Colorado Denver

Public Release: 12-Mar-2013
Carcinogenesis
Bitter melon juice prevents pancreatic cancer in mouse models
A University of Colorado Cancer study published today in the journal Carcinogenesis shows that bitter melon juice restricts the ability of pancreatic cancer cells to metabolize glucose, thus cutting the cells' energy source and eventually killing them.
National Institutes of Health

Contact: Garth Sundem
garth.sundem@ucdenver.edu
University of Colorado Denver

Public Release: 12-Mar-2013
Infection and Immunity
Some bacteria may protect against disease caused by stomach infection
Half of the world's human population is infected with the stomach bacteria called Helicobacter pylori, yet it causes disease in only about 10 percent of those infected. Other bacteria living in the stomach may be a key factor in whether or not H. pylori causes disease, according to a new study led by scientists at the University of California, Santa Cruz.
National Institutes of Health, UC Cancer Research Coordinating Committee

Contact: Tim Stephens
stephens@ucsc.edu
831-459-2495
University of California - Santa Cruz

Public Release: 12-Mar-2013
JAMA Facial Plastic Surgery
Repairing the nose after skin cancer in just one step
A new reconstruction technique allows surgeons to recreate a functioning nostril after removing skin cancer from the nose. The technique takes only one step, unlike the current practice that requires a return trip the operating room.

Contact: Nicole Fawcett
nfawcett@umich.edu
734-764-2220
University of Michigan Health System

Public Release: 12-Mar-2013
Radiology
RI Hospital: Radiation can be reduced while maintaining high quality in CT colonography
A new study by a Rhode Island Hospital researcher has found it's possible to maintain high-quality CT colonography diagnostic images while reducing the radiation dose. This is important as the use of CT colonography, or virtual colonoscopy, becomes more widely used for colorectal cancer screenings. The paper, by Kevin J. Chang, M.D., is published in the current issue of the journal Radiology.

Contact: Ellen Slingsby
eslinsby@lifespan.org
401-444-6421
Lifespan

Public Release: 11-Mar-2013
Oncogene
Therapies for ALL and AML targeting MER receptor hold promise of more effect with less side-effect
Two University of Colorado Cancer Center studies show that the protein receptor Mer is overexpressed in many leukemias, and that inhibition of this Mer receptor results in the death of leukemia cells -- without affecting surrounding, healthy cells.

Contact: Garth Sundem
garth.sundem@ucdenver.edu
University of Colorado Denver

Public Release: 11-Mar-2013
Cancer Epidemiology, Biomarkers & Prevention
Trio of biomarkers may help identify kidney cancer in early stages
Biomarkers could help catch otherwise hard-to-detect cancer. Three-marker assay has high sensitivity and specificity. Researchers are seeking FDA approval.

Contact: Jeremy Moore
jeremy.moore@aacr.org
215-446-7109
American Association for Cancer Research

Public Release: 11-Mar-2013
Cancer
Aspirin may lower melanoma risk
A new study has found that women who take aspirin have a reduced risk of developing melanoma -- and that the longer they take it, the lower the risk. The findings suggest that aspirin's anti-inflammatory effects may help protect against this type of skin cancer. The study is published early online in CANCER, a peer-reviewed journal of the American Cancer Society.

Contact: Amy Molnar
sciencenewsroom@wiley.com
Wiley

Public Release: 11-Mar-2013
Journal of Clinical Oncology
Analysis of ASCO's QOPI® data finds significant improvement in performance on metrics for quality oncology care
This is a summary of a study being published online March 11, 2013, in the Journal of Clinical Oncology, analyzing self-reported data from 156 outpatient oncology practices participating in the American Society of Clinical Oncology's Quality Oncology Practice Initiative showing significant improvements in performance on certain measures for quality oncology cancer care over a four-year period.

Contact: Aaron Tallent
Aaron.Tallent@asco.org
571-483-1371
American Society of Clinical Oncology

Public Release: 11-Mar-2013
JAMA Internal Medicine
Regenstrief and IU study investigates older adults' views on cancer screening
A study from the Regenstrief Institute and the Indiana University Center for Aging Research has found that many older adults are hesitant to halt cancer screenings even when the screenings may no longer be beneficial or may even be potentially harmful.
NIH/National Institute on Aging

Contact: Cindy Fox Aisen
caisen@iupui.edu
317-843-2276
Indiana University

Public Release: 11-Mar-2013
Nucleic Acids Research
Protein abundant in cancerous cells causes DNA 'supercoiling'
An overabundance of MCM in a cell may allow certain genes to be over-expressed causing the cell to grow out of control and become cancerous.
NIH/National Human Genome Research Institute

Contact: Robert Perkins
perkinsr@usc.edu
213-740-9226
University of Southern California

Public Release: 8-Mar-2013
Science
Anti-aging drug breakthrough
Drugs that combat aging may be available within five years, following landmark work led by an Australian researcher.

Contact: Susi Hamilton
susi.hamilton@unsw.edu.au
61-422-934-024
University of New South Wales

Public Release: 8-Mar-2013
Journal of Clinical Investigation
JCI early table of contents for March 8, 2013
This release contains summaries, links to PDFs, and contact information for the following newsworthy papers to be published online, March 8, 2013, in the JCI: Enhanced brain acetate metabolism may reward heavy drinkers; Fully wired: planar cell polarity genes guide gut neurons; and many more.

Contact: Jillian Hurst
press_releases@the-jci.org
Journal of Clinical Investigation

Public Release: 8-Mar-2013
Supportive Care in Cancer
Wayne State researcher gives new name to exhaustion suffered by cancer patients
The fatigue experienced by patients undergoing cancer treatments has long been recognized by health care providers, although its causes and ways to manage it are still largely unknown. A Wayne State University researcher believes the condition affects some patients much more than others and is trying to determine the nature of that difference.
Oncology Nursing Foundation

Contact: Julie O'Connor
julie.oconnor@wayne.edu
313-577-8845
Wayne State University - Office of the Vice President for Research

Public Release: 8-Mar-2013
Cancer Cell
BRAF inhibitor treatment causes melanoma cells to shift how they produce energy
A multi-institutional study has revealed that BRAF-positive metastatic malignant melanomas develop resistance to treatment with drugs targeting the BRAF/MEK growth pathway through a major change in metabolism. The findings, which will be published in Cancer Cell and have been released online, suggest a strategy to improve the effectiveness of currently available targeted therapies.
NIH/National Cancer Institute, NIH/National Insititute of Arthritis and Musculoskeletal and Skin Diseases, Melanoma Research Alliance, Dr. Miriam and Sheldon G. Adelson Medical Research Foundation

Contact: Michelle Marcella
mmarcella@partners.org
617-724-2755
Massachusetts General Hospital

Public Release: 8-Mar-2013
Health Psychology
Study shows confidence builds better exercise habits for cancer survivors
Endometrial cancer survivors are more likely to complete physical activity, and for longer durations, when their daily self-efficacy is higher, according to a study published online in the journal Health Psychology -- a publication of the American Psychology Association.

Contact: Katrina Burton
kburton@mdanderson.org
713-792-8034
University of Texas M. D. Anderson Cancer Center

Public Release: 7-Mar-2013
Journal of Clinical Oncology
Comparing combination therapies for advanced head and neck cancer shows no improvement
A team of scientists reports results of a clinical trial comparing combination treatments for head and neck cancer.
Genentech, Astellas Pharma Global Development

Contact: Dianne Shaw
dgs@med.unc.edu
919-966-7834
University of North Carolina Health Care

Public Release: 7-Mar-2013
Nature
Scientists uncover source of ovarian stem-like cells prone to give rise to ovarian cancer
In collaboration with colleagues at Cornell University, a team of cancer researchers at Cold Spring Harbor Laboratory has discovered cells with stem-cell properties in the ovary that can mutate to form tumors.
NIH/National Cancer Institute, National Institiutes of Health, New York State Stem Cell Science, Rivkin Center for Ovarian Cancer

Contact: Peter Tarr
tarr@cshl.edu
516-367-8455
Cold Spring Harbor Laboratory

Showing releases 976-1000 out of 1212.

<< < 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 > >>

  Search News Releases

     

 

 

EurekAlert!